Affinity chromatography of tryptases: Design, synthesis and characterization of a novel matrix-bound bivalent inhibitor

Schaschke N, Gabrijelcic-Geiger D, Dominik A, Sommerhoff CP (2005)
CHEMBIOCHEM 6(1): 95-103.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
; ; ;
Erscheinungsjahr
Zeitschriftentitel
CHEMBIOCHEM
Band
6
Zeitschriftennummer
1
Seite
95-103
ISSN
PUB-ID

Zitieren

Schaschke N, Gabrijelcic-Geiger D, Dominik A, Sommerhoff CP. Affinity chromatography of tryptases: Design, synthesis and characterization of a novel matrix-bound bivalent inhibitor. CHEMBIOCHEM. 2005;6(1):95-103.
Schaschke, N., Gabrijelcic-Geiger, D., Dominik, A., & Sommerhoff, C. P. (2005). Affinity chromatography of tryptases: Design, synthesis and characterization of a novel matrix-bound bivalent inhibitor. CHEMBIOCHEM, 6(1), 95-103. doi:10.1002/cbic.200400217
Schaschke, N., Gabrijelcic-Geiger, D., Dominik, A., and Sommerhoff, C. P. (2005). Affinity chromatography of tryptases: Design, synthesis and characterization of a novel matrix-bound bivalent inhibitor. CHEMBIOCHEM 6, 95-103.
Schaschke, N., et al., 2005. Affinity chromatography of tryptases: Design, synthesis and characterization of a novel matrix-bound bivalent inhibitor. CHEMBIOCHEM, 6(1), p 95-103.
N. Schaschke, et al., “Affinity chromatography of tryptases: Design, synthesis and characterization of a novel matrix-bound bivalent inhibitor”, CHEMBIOCHEM, vol. 6, 2005, pp. 95-103.
Schaschke, N., Gabrijelcic-Geiger, D., Dominik, A., Sommerhoff, C.P.: Affinity chromatography of tryptases: Design, synthesis and characterization of a novel matrix-bound bivalent inhibitor. CHEMBIOCHEM. 6, 95-103 (2005).
Schaschke, Norbert, Gabrijelcic-Geiger, D, Dominik, A, and Sommerhoff, CP. “Affinity chromatography of tryptases: Design, synthesis and characterization of a novel matrix-bound bivalent inhibitor”. CHEMBIOCHEM 6.1 (2005): 95-103.

7 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Human Mast Cell Tryptase Is a Potential Treatment for Snakebite Envenoming Across Multiple Snake Species.
Anderson E, Stavenhagen K, Kolarich D, Sommerhoff CP, Maurer M, Metz M., Front Immunol 9(), 2018
PMID: 30038613
Shedding of the coronary endothelial glycocalyx: effects of hypoxia/reoxygenation vs ischaemia/reperfusion.
Annecke T, Fischer J, Hartmann H, Tschoep J, Rehm M, Conzen P, Sommerhoff CP, Becker BF., Br J Anaesth 107(5), 2011
PMID: 21890663
Inosine, not adenosine, initiates endothelial glycocalyx degradation in cardiac ischemia and hypoxia.
Becker BF, Fischer J, Hartmann H, Chen CC, Sommerhoff CP, Tschoep J, Conzen PC, Annecke T., Nucleosides Nucleotides Nucleic Acids 30(12), 2011
PMID: 22132971
Sevoflurane preserves the endothelial glycocalyx against ischaemia-reperfusion injury.
Annecke T, Chappell D, Chen C, Jacob M, Welsch U, Sommerhoff CP, Rehm M, Conzen PF, Becker BF., Br J Anaesth 104(4), 2010
PMID: 20172938
Protease-activated receptor 2 mediates the proinflammatory effects of synovial mast cells.
Palmer HS, Kelso EB, Lockhart JC, Sommerhoff CP, Plevin R, Goh FG, Ferrell WR., Arthritis Rheum 56(11), 2007
PMID: 17968878
Biology of mast cell tryptase. An inflammatory mediator.
Hallgren J, Pejler G., FEBS J 273(9), 2006
PMID: 16640553

35 References

Daten bereitgestellt von Europe PubMed Central.

Selective enzyme purification by affinity chromatography.
Cuatrecasas P, Wilchek M, Anfinsen CB., Proc. Natl. Acad. Sci. U.S.A. 61(2), 1968
PMID: 4971842
Design and selection of ligands for affinity chromatography.
Labrou NE., J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 790(1-2), 2003
PMID: 12767321

Fritz, Angew. Chem. 78(), 1966
Isolation of protease inhibitors.
Fritz H, Schult H, Neudecker M, Werle E., Angew. Chem. Int. Ed. Engl. 5(8), 1966
PMID: 4962481
[Use of water-insoluble derivatives of the trypsin-kallikrein inhibitor for the isolation of kallikrein and plasmin]
Fritz H, Brey B, Schmal A, Werle E., Hoppe-Seyler's Z. Physiol. Chem. 350(5), 1969
PMID: 4239805
Purification of active calpain by affinity chromatography on an immobilized peptide inhibitor.
Anagli J, Vilei EM, Molinari M, Calderara S, Carafoli E., Eur. J. Biochem. 241(3), 1996
PMID: 8944787
Peptide boronic acids. Versatile synthetic ligands for affinity chromatography of serine proteinases.
Zembower DE, Neudauer CL, Wick MJ, Ames MM., Int. J. Pept. Protein Res. 47(5), 1996
PMID: 8791164

Johnson, 1998
The human mast cell tryptase tetramer: a fascinating riddle solved by structure.
Sommerhoff CP, Bode W, Matschiner G, Bergner A, Fritz H., Biochim. Biophys. Acta 1477(1-2), 2000
PMID: 10708850
Mast cell tryptases and airway remodeling.
Sommerhoff CP., Am. J. Respir. Crit. Care Med. 164(10 Pt 2), 2001
PMID: 11734467

AUTHOR UNKNOWN, 1995
Of mites and men: trypsin-like proteases in the lungs.
Caughey GH., Am. J. Respir. Cell Mol. Biol. 16(6), 1997
PMID: 9191463

Abraham, Am. J. Physiol. 282(), 2002

Rice, Expert Opin. Ther. Pat. 9(), 1999
Human beta-tryptase is a ring-like tetramer with active sites facing a central pore.
Pereira PJ, Bergner A, Macedo-Ribeiro S, Huber R, Matschiner G, Fritz H, Sommerhoff CP, Bode W., Nature 392(6673), 1998
PMID: 9521329
The structure of the human betaII-tryptase tetramer: fo(u)r better or worse.
Sommerhoff CP, Bode W, Pereira PJ, Stubbs MT, Sturzebecher J, Piechottka GP, Matschiner G, Bergner A., Proc. Natl. Acad. Sci. U.S.A. 96(20), 1999
PMID: 10500112
Potent selective nonpeptidic inhibitors of human lung tryptase.
Burgess LE, Newhouse BJ, Ibrahim P, Rizzi J, Kashem MA, Hartman A, Brandhuber BJ, Wright CD, Thomson DS, Vigers GP, Koch K., Proc. Natl. Acad. Sci. U.S.A. 96(15), 1999
PMID: 10411878
Syntheses and evaluation of amidinobenzofuran derivatives as tryptase inhibitors.
Ono S, Kuwahara S, Takeuchi M, Sakashita H, Naito Y, Kondo T., Bioorg. Med. Chem. Lett. 9(23), 1999
PMID: 10612586
Dibasic inhibitors of human mast cell tryptase. Part 1: synthesis and optimization of a novel class of inhibitors.
Rice KD, Gangloff AR, Kuo EY, Dener JM, Wang VR, Lum R, Newcomb WS, Havel C, Putnam D, Cregar L, Wong M, Warne RL., Bioorg. Med. Chem. Lett. 10(20), 2000
PMID: 11055355
Dibasic inhibitors of human mast cell tryptase. Part 2: structure-activity relationships and requirements for potent activity.
Rice KD, Wang VR, Gangloff AR, Kuo EY, Dener JM, Newcomb WS, Young WB, Putnam D, Cregar L, Wong M, Simpson PJ., Bioorg. Med. Chem. Lett. 10(20), 2000
PMID: 11055356
Bivalent inhibition of human beta-tryptase.
Schaschke N, Matschiner G, Zettl F, Marquardt U, Bergner A, Bode W, Sommerhoff CP, Moroder L., Chem. Biol. 8(4), 2001
PMID: 11325588
Dibasic inhibitors of human mast cell tryptase. Part 3: identification of a series of potent and selective inhibitors containing the benzamidine functionality.
Dener JM, Rice KD, Newcomb WS, Wang VR, Young WB, Gangloff AR, Kuo EY, Cregar L, Putnam D, Wong M., Bioorg. Med. Chem. Lett. 11(13), 2001
PMID: 11425524
Bivalent inhibition of beta-tryptase: distance scan of neighboring subunits by dibasic inhibitors.
Schaschke N, Dominik A, Matschiner G, Sommerhoff CP., Bioorg. Med. Chem. Lett. 12(6), 2002
PMID: 11959009

Falorni, Tetrahedron Lett. 38(), 1997
Characterization of genes encoding known and novel human mast cell tryptases on chromosome 16p13.3.
Pallaoro M, Fejzo MS, Shayesteh L, Blount JL, Caughey GH., J. Biol. Chem. 274(6), 1999
PMID: 9920877
Characterization of human gamma-tryptases, novel members of the chromosome 16p mast cell tryptase and prostasin gene families.
Caughey GH, Raymond WW, Blount JL, Hau LW, Pallaoro M, Wolters PJ, Verghese GM., J. Immunol. 164(12), 2000
PMID: 10843716
Human tryptase epsilon (PRSS22), a new member of the chromosome 16p13.3 family of human serine proteases expressed in airway epithelial cells.
Wong GW, Yasuda S, Madhusudhan MS, Li L, Yang Y, Krilis SA, Sali A, Stevens RL., J. Biol. Chem. 276(52), 2001
PMID: 11602603
The Protein Data Bank.
Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE., Nucleic Acids Res. 28(1), 2000
PMID: 10592235

AUTHOR UNKNOWN, 0

Kramer, Med. Chem. Res. 9(), 1999

Halgren, J. Am. Chem. Soc. 112(), 1990
A Kazal-type inhibitor of human mast cell tryptase: isolation from the medical leech Hirudo medicinalis, characterization, and sequence analysis.
Sommerhoff CP, Sollner C, Mentele R, Piechottka GP, Auerswald EA, Fritz H., Biol. Chem. Hoppe-Seyler 375(10), 1994
PMID: 7888081

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 15593113
PubMed | Europe PMC

Suchen in

Google Scholar